img

Global Drug Repositioning Service Market Size, Status and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 102 | Industry : Service & Software

Publisher : QY | Format : PDF

Global Drug Repositioning Service Market Size, Status and Forecast 2024-2034

Drug Repositioning Service market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Repositioning Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Generic Drugs
Clinical Trial Failed Drugs


Segment by Application


Cardiovascular Diseases
Mental Illness
Cancer
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA




By Company


Biovista
Anaxomics Biotech
Segue Therapeutics
GVK Biosciences

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repositioning Service Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Drug Repositioning Service Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Drug Repositioning Service Market Perspective (2016-2027)
2.2 Drug Repositioning Service Growth Trends by Regions
2.2.1 Drug Repositioning Service Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Repositioning Service Historic Market Share by Regions (2016-2021)
2.2.3 Drug Repositioning Service Forecasted Market Size by Regions (2022-2027)
2.3 Drug Repositioning Service Industry Dynamic
2.3.1 Drug Repositioning Service Market Trends
2.3.2 Drug Repositioning Service Market Drivers
2.3.3 Drug Repositioning Service Market Challenges
2.3.4 Drug Repositioning Service Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Drug Repositioning Service Players by Revenue
3.1.1 Global Top Drug Repositioning Service Players by Revenue (2016-2021)
3.1.2 Global Drug Repositioning Service Revenue Market Share by Players (2016-2021)
3.2 Global Drug Repositioning Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Repositioning Service Revenue
3.4 Global Drug Repositioning Service Market Concentration Ratio
3.4.1 Global Drug Repositioning Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Service Revenue in 2020
3.5 Drug Repositioning Service Key Players Head office and Area Served
3.6 Key Players Drug Repositioning Service Product Solution and Service
3.7 Date of Enter into Drug Repositioning Service Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Repositioning Service Breakdown Data by Type
4.1 Global Drug Repositioning Service Historic Market Size by Type (2016-2021)
4.2 Global Drug Repositioning Service Forecasted Market Size by Type (2022-2027)

5 Drug Repositioning Service Breakdown Data by Application
5.1 Global Drug Repositioning Service Historic Market Size by Application (2016-2021)
5.2 Global Drug Repositioning Service Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Drug Repositioning Service Market Size (2016-2027)
6.2 North America Drug Repositioning Service Market Size by Type
6.2.1 North America Drug Repositioning Service Market Size by Type (2016-2021)
6.2.2 North America Drug Repositioning Service Market Size by Type (2022-2027)
6.2.3 North America Drug Repositioning Service Market Size by Type (2016-2027)
6.3 North America Drug Repositioning Service Market Size by Application
6.3.1 North America Drug Repositioning Service Market Size by Application (2016-2021)
6.3.2 North America Drug Repositioning Service Market Size by Application (2022-2027)
6.3.3 North America Drug Repositioning Service Market Size by Application (2016-2027)
6.4 North America Drug Repositioning Service Market Size by Country
6.4.1 North America Drug Repositioning Service Market Size by Country (2016-2021)
6.4.2 North America Drug Repositioning Service Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Drug Repositioning Service Market Size (2016-2027)
7.2 Europe Drug Repositioning Service Market Size by Type
7.2.1 Europe Drug Repositioning Service Market Size by Type (2016-2021)
7.2.2 Europe Drug Repositioning Service Market Size by Type (2022-2027)
7.2.3 Europe Drug Repositioning Service Market Size by Type (2016-2027)
7.3 Europe Drug Repositioning Service Market Size by Application
7.3.1 Europe Drug Repositioning Service Market Size by Application (2016-2021)
7.3.2 Europe Drug Repositioning Service Market Size by Application (2022-2027)
7.3.3 Europe Drug Repositioning Service Market Size by Application (2016-2027)
7.4 Europe Drug Repositioning Service Market Size by Country
7.4.1 Europe Drug Repositioning Service Market Size by Country (2016-2021)
7.4.2 Europe Drug Repositioning Service Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Drug Repositioning Service Market Size (2016-2027)
8.2 Asia-Pacific Drug Repositioning Service Market Size by Type
8.2.1 Asia-Pacific Drug Repositioning Service Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Repositioning Service Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Repositioning Service Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Repositioning Service Market Size by Application
8.3.1 Asia-Pacific Drug Repositioning Service Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Repositioning Service Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Repositioning Service Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Repositioning Service Market Size by Region
8.4.1 Asia-Pacific Drug Repositioning Service Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Repositioning Service Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Drug Repositioning Service Market Size (2016-2027)
9.2 Latin America Drug Repositioning Service Market Size by Type
9.2.1 Latin America Drug Repositioning Service Market Size by Type (2016-2021)
9.2.2 Latin America Drug Repositioning Service Market Size by Type (2022-2027)
9.2.3 Latin America Drug Repositioning Service Market Size by Type (2016-2027)
9.3 Latin America Drug Repositioning Service Market Size by Application
9.3.1 Latin America Drug Repositioning Service Market Size by Application (2016-2021)
9.3.2 Latin America Drug Repositioning Service Market Size by Application (2022-2027)
9.3.3 Latin America Drug Repositioning Service Market Size by Application (2016-2027)
9.4 Latin America Drug Repositioning Service Market Size by Country
9.4.1 Latin America Drug Repositioning Service Market Size by Country (2016-2021)
9.4.2 Latin America Drug Repositioning Service Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Drug Repositioning Service Market Size (2016-2027)
10.2 Middle East & Africa Drug Repositioning Service Market Size by Type
10.2.1 Middle East & Africa Drug Repositioning Service Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Repositioning Service Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Repositioning Service Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Repositioning Service Market Size by Application
10.3.1 Middle East & Africa Drug Repositioning Service Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Repositioning Service Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Repositioning Service Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Repositioning Service Market Size by Country
10.4.1 Middle East & Africa Drug Repositioning Service Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Repositioning Service Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biovista
11.1.1 Biovista Company Details
11.1.2 Biovista Business Overview
11.1.3 Biovista Drug Repositioning Service Introduction
11.1.4 Biovista Revenue in Drug Repositioning Service Business (2016-2021)
11.1.5 Biovista Recent Development
11.2 Anaxomics Biotech
11.2.1 Anaxomics Biotech Company Details
11.2.2 Anaxomics Biotech Business Overview
11.2.3 Anaxomics Biotech Drug Repositioning Service Introduction
11.2.4 Anaxomics Biotech Revenue in Drug Repositioning Service Business (2016-2021)
11.2.5 Anaxomics Biotech Recent Development
11.3 Segue Therapeutics
11.3.1 Segue Therapeutics Company Details
11.3.2 Segue Therapeutics Business Overview
11.3.3 Segue Therapeutics Drug Repositioning Service Introduction
11.3.4 Segue Therapeutics Revenue in Drug Repositioning Service Business (2016-2021)
11.3.5 Segue Therapeutics Recent Development
11.4 GVK Biosciences
11.4.1 GVK Biosciences Company Details
11.4.2 GVK Biosciences Business Overview
11.4.3 GVK Biosciences Drug Repositioning Service Introduction
11.4.4 GVK Biosciences Revenue in Drug Repositioning Service Business (2016-2021)
11.4.5 GVK Biosciences Recent Development
11.5 LTT Bio-Pharma
11.5.1 LTT Bio-Pharma Company Details
11.5.2 LTT Bio-Pharma Business Overview
11.5.3 LTT Bio-Pharma Drug Repositioning Service Introduction
11.5.4 LTT Bio-Pharma Revenue in Drug Repositioning Service Business (2016-2021)
11.5.5 LTT Bio-Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug Repositioning Service Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Generic Drugs
Table 3. Key Players of Clinical Trial Failed Drugs
Table 4. Global Drug Repositioning Service Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Drug Repositioning Service Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Drug Repositioning Service Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Drug Repositioning Service Market Share by Regions (2016-2021)
Table 8. Global Drug Repositioning Service Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Drug Repositioning Service Market Share by Regions (2022-2027)
Table 10. Drug Repositioning Service Market Trends
Table 11. Drug Repositioning Service Market Drivers
Table 12. Drug Repositioning Service Market Challenges
Table 13. Drug Repositioning Service Market Restraints
Table 14. Global Drug Repositioning Service Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Drug Repositioning Service Market Share by Players (2016-2021)
Table 16. Global Top Drug Repositioning Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repositioning Service as of 2020)
Table 17. Ranking of Global Top Drug Repositioning Service Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Drug Repositioning Service Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Repositioning Service Product Solution and Service
Table 21. Date of Enter into Drug Repositioning Service Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Repositioning Service Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Drug Repositioning Service Revenue Market Share by Type (2016-2021)
Table 25. Global Drug Repositioning Service Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Drug Repositioning Service Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Drug Repositioning Service Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Drug Repositioning Service Revenue Market Share by Application (2016-2021)
Table 29. Global Drug Repositioning Service Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Drug Repositioning Service Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Drug Repositioning Service Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Drug Repositioning Service Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Drug Repositioning Service Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Drug Repositioning Service Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Drug Repositioning Service Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Drug Repositioning Service Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Drug Repositioning Service Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Drug Repositioning Service Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Drug Repositioning Service Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Drug Repositioning Service Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Drug Repositioning Service Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Drug Repositioning Service Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Drug Repositioning Service Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Drug Repositioning Service Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Drug Repositioning Service Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Drug Repositioning Service Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Drug Repositioning Service Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Drug Repositioning Service Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Drug Repositioning Service Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Drug Repositioning Service Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Drug Repositioning Service Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Drug Repositioning Service Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Drug Repositioning Service Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Drug Repositioning Service Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Drug Repositioning Service Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Drug Repositioning Service Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Drug Repositioning Service Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Drug Repositioning Service Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Drug Repositioning Service Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Drug Repositioning Service Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biovista Company Details
Table 62. Biovista Business Overview
Table 63. Biovista Drug Repositioning Service Product
Table 64. Biovista Revenue in Drug Repositioning Service Business (2016-2021) & (US$ Million)
Table 65. Biovista Recent Development
Table 66. Anaxomics Biotech Company Details
Table 67. Anaxomics Biotech Business Overview
Table 68. Anaxomics Biotech Drug Repositioning Service Product
Table 69. Anaxomics Biotech Revenue in Drug Repositioning Service Business (2016-2021) & (US$ Million)
Table 70. Anaxomics Biotech Recent Development
Table 71. Segue Therapeutics Company Details
Table 72. Segue Therapeutics Business Overview
Table 73. Segue Therapeutics Drug Repositioning Service Product
Table 74. Segue Therapeutics Revenue in Drug Repositioning Service Business (2016-2021) & (US$ Million)
Table 75. Segue Therapeutics Recent Development
Table 76. GVK Biosciences Company Details
Table 77. GVK Biosciences Business Overview
Table 78. GVK Biosciences Drug Repositioning Service Product
Table 79. GVK Biosciences Revenue in Drug Repositioning Service Business (2016-2021) & (US$ Million)
Table 80. GVK Biosciences Recent Development
Table 81. LTT Bio-Pharma Company Details
Table 82. LTT Bio-Pharma Business Overview
Table 83. LTT Bio-Pharma Drug Repositioning Service Product
Table 84. LTT Bio-Pharma Revenue in Drug Repositioning Service Business (2016-2021) & (US$ Million)
Table 85. LTT Bio-Pharma Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Repositioning Service Market Share by Type: 2020 VS 2027
Figure 2. Generic Drugs Features
Figure 3. Clinical Trial Failed Drugs Features
Figure 4. Global Drug Repositioning Service Market Share by Application: 2020 VS 2027
Figure 5. Cardiovascular Diseases Case Studies
Figure 6. Mental Illness Case Studies
Figure 7. Cancer Case Studies
Figure 8. Other Case Studies
Figure 9. Drug Repositioning Service Report Years Considered
Figure 10. Global Drug Repositioning Service Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Drug Repositioning Service Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Drug Repositioning Service Market Share by Regions: 2020 VS 2027
Figure 13. Global Drug Repositioning Service Market Share by Regions (2022-2027)
Figure 14. Global Drug Repositioning Service Market Share by Players in 2020
Figure 15. Global Top Drug Repositioning Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repositioning Service as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Drug Repositioning Service Revenue in 2020
Figure 17. Global Drug Repositioning Service Revenue Market Share by Type (2016-2021)
Figure 18. Global Drug Repositioning Service Revenue Market Share by Type (2022-2027)
Figure 19. North America Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Drug Repositioning Service Market Share by Type (2016-2027)
Figure 21. North America Drug Repositioning Service Market Share by Application (2016-2027)
Figure 22. North America Drug Repositioning Service Market Share by Country (2016-2027)
Figure 23. United States Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Drug Repositioning Service Market Share by Type (2016-2027)
Figure 27. Europe Drug Repositioning Service Market Share by Application (2016-2027)
Figure 28. Europe Drug Repositioning Service Market Share by Country (2016-2027)
Figure 29. Germany Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Drug Repositioning Service Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Drug Repositioning Service Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Drug Repositioning Service Market Share by Region (2016-2027)
Figure 39. China Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Drug Repositioning Service Market Share by Type (2016-2027)
Figure 47. Latin America Drug Repositioning Service Market Share by Application (2016-2027)
Figure 48. Latin America Drug Repositioning Service Market Share by Country (2016-2027)
Figure 49. Mexico Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Drug Repositioning Service Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Drug Repositioning Service Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Drug Repositioning Service Market Share by Country (2016-2027)
Figure 55. Turkey Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Drug Repositioning Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Biovista Revenue Growth Rate in Drug Repositioning Service Business (2016-2021)
Figure 59. Anaxomics Biotech Revenue Growth Rate in Drug Repositioning Service Business (2016-2021)
Figure 60. Segue Therapeutics Revenue Growth Rate in Drug Repositioning Service Business (2016-2021)
Figure 61. GVK Biosciences Revenue Growth Rate in Drug Repositioning Service Business (2016-2021)
Figure 62. LTT Bio-Pharma Revenue Growth Rate in Drug Repositioning Service Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed